This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Stephens, M.D.B. Search for Related Content PubMed Articles by Stephens, M.D.B. Social Bookmarking                         What's this?

Drug-induced Piloerection in Man: an 1-Adrenoceptor Agonist Effect?

Drug Surveillance Department, Glaxo Group Research Limited, Ware, Hertfordshire, UK

1 The physiology of piloerection is described and clinical experience is discussed.

2 The objective and subjective evidence for drug-induced piloerection by a number of drugs is given and, where it is known, their pharmacological mechanism is described.

3 The results are considered in relation to the hypothesis that drug-induced piloerection is only produced by drugs with ₁-adrenoceptor agonist activity. For those drugs without the latter activity where piloerection is supported only by subjective evidence it is suggested that objective evidence should be sought.

4 The fact that there is no objective evidence that the classical ₁-adrenoceptor agonist, phenylephrine, produces piloerection is found surprising and it is suggested that such evidence should be sought. If it is found that phenylephrine does not produce piloerection, then the possibility of the existence of a further -agonist subgroup needs to be considered.

Human & Experimental Toxicology, Vol. 5, No. 5, 319-324 (1986)
DOI: 10.1177/096032718600500504


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?